Navigation Links
Light at the end of the tunnel for patients suffering Keratoconus.

A novel treatment that utilizes a certain dose of light and vitamin B2, promises to be an eye opener to nearly tens and thousands of Australians. // It is well known that almost 10,000 Australians suffer a degenerative disease of the eyes, called keratoconus, which can ultimately lead to blindness.

The envisaged treatment will entail application of drops of riboflavin (vitamin B2) after the “skin” of the eye is removed, and allow the UVA light to fall on the eye, which will strengthen the cornea. This treatment will not improve the eyesight but it will certainly arrest further degeneration and even prevent blindness.

A trial of this treatment procedure, due to commence at the Royal Victorian Eye and Ear Hospital, will be sponsored by the state government. The trial will be led by Christine Wittig, who had started off the procedure initially and has been offering this service in Germany over the past five years. According to her, the success rate is nearly 100% with no apparent long term complications.

Nearly 100 patients will participate in a randomized trial after which the hospital has indicated the availability of the procedure to patients next year. Corneal transplants, are infamous due to their long waiting period, next only to kidney transplants, and with the new treatment, some of the pressure of long waiting periods will certainly ease off. It is estimated that nearly 300 corneal transplants take place in Victoria each year, and 50% of these transplants are for patients with keratoconus.


'"/>




Page: 1

Related medicine news :

1. Light therapy decreases depression during pregnancy
2. Light therapy devotes new hope in advanced lung cancer
3. Reducing TB With Ultraviolet Light
4. Exposure To Night Light may Increase The Risk Of Leukemia
5. Improving Lighting Could Bring About A Change In Alzheimers Patients
6. Light Cigarettes - Not So Light?
7. Fungal Infections Effectively Controlled By Light Therapy
8. Light can help fight gum bacteria
9. Lights can lighten your moods
10. Night Light Found To Increase The Risk Of Leukemia
11. UV- Light Tanning As A Type Of Substance-Related Disorder
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... ... 2017 , ... People are starting to accept that hearing aids can be ... the stigma it had when great-grandpa wore his hearing aids years ago,” said Dr. ... North American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates ... leading ERP expert that specializes in long-term care, Brooke Grove now has the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. , with ... B. Braun Medical Inc. , a leader in infusion therapy and pain management. ... many as 90 percent of hospital patients receiving a peripheral IV catheter as part ...
(Date:4/27/2017)... ... April 27, 2017 , ... The ... the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a prestigious ... Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. Attorney ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... of its senior management team will host a conference call and ... The dial-in number to access the call is ... the passcode is 6086379. Please dial in 10 minutes prior to ... replay of the call will be available from May 9, 2017 ...
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
Breaking Medicine Technology: